Today’s Solutions: April 21, 2024

The shoe industry has a massive carbon footprint. That’s why Reebok is now creating shoes using plant-based materials to clean up both production and post-consumer use in an industry that typically relies on petroleum in manufacturing.

In addition to using 100 percent organic cotton for the shoe’s upper, Reebok’s latest sneakers use a corn product to create a bioplastic sole and castor bean oil for the insole. Reebok takes the environmentally friendly process one step further by composting old shoes for use in the production of future products. The shoes from this environmentally-friendly sneaker line is the first ever to be certified by the USDA as containing 75 percent bio-based materials.

Check out the article below to learn more about the shoe’s production and how Reebok’s technology can be applied to improve the sustainability of the 20 billion shoes produced globally each year.

EDITORIAL UPDATE: Following a successful launch, the first run of the new NPC UK Cotton + Corn sneaker is currently sold out. Company representative Lizzy Manno reports that Reebok does not yet have a date for when the shoes will be in stock again, but we certainly can’t wait until these plant-based sneakers are back on the market.


Solutions News Source Print this article
More of Today's Solutions

3 simple ways to save an extra $250 per month

Everyone loves to save money, so here are three easy ways you can free up $250 in your budget per month. Cancel subscriptions you ...

Read More

APA, AAPI, APIDA or AANHPI? The history and significance of the “Asian Americ...

“The journey of a thousand miles begins with one step.” ― Lao Tzu By Arielle Tiangco Weeks ago, seated cross-legged on my couch, I ...

Read More

Playing video games benefit key regions of the brain

A recent study from Georgia State University found that sensorimotor decision-making skills were superior in regular video game players to those that didn’t play ...

Read More

Novel blood cancer treatment effective in three-fourths of trial patients

According to new findings from an ongoing Phase 1/2 clinical research trial, a novel investigational immunotherapy resulted in successful response rates for 73 percent ...

Read More